Use of OM-85 BV in primary prevention of acute respiratory tract infections in children in orphanages

Current Therapeutic Research - Clinical and Experimental

Volumn 59, Issue 6, 1998, Pages 407-418

  Field, Jorge ^a   Gómez Barreto, Demóstentes ^b   Del Río Navarro, Blanca Estela ^b   Berber, Arturo ^c  

^a Children Kingdom   (Mexico)

^b HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^c BASF Mexicana SA de CV   (Mexico)

Author keywords

Children; OM 85 BV; Orphanages; Respiratory tract infection

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM LYSATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ABSENTEEISM; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DRUG CAPSULE; DRUG EFFECT; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEXICO; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; ORPHANAGE; PRIMARY PREVENTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

EID: 0031842817     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(98)85044-3     Document Type: Article

References (59)

1. Kirkwood BR, Gove S, Rogers S, et al. Potential interventions for the prevention of childhood pneumonia in developing countries: A systematic review. Bull WHO. 1995;73:793-798.
2. Berman S. Epidemiology of acute respiratory infections in children of developing countries. Rev Infect Dis. 1991;13(Suppl 6):154-162.
3. Erwick-Roberts J, Burchinal MR, Collier AM, et al. Otitis media in early childhood and cognitive, academic and classroom performance of the school-aged child. Pediatrics. 1989;83:477-485.
4. Schwartz B, Giebink GS, Henderson FW, et al. Respiratory infections in day care. Pediatrics. 1994;94:1018-1020.
5. Hardy AM, Fowler MG. Child care arrangements and repeated ear infections in young children. Am J Public Health. 1993;83:1321-1325.
6. Denny FW, Collier AM, Henderson FW. Acute respiratory infections in day care. Rev Infect Dis. 1986;8:527-532.
7. Haskins R, Kotch J. Day care and illness: Evidence, costs, and public policy. Pediatrics. 1986(Suppl 2);77:951-982.
8. Bell DM, Gleiber DW, Mercer AA, et al. Illness associated with child day care: A study of incidence and cost. Am J Public Health. 1989;79:479-484.
9. Selwyn BJ. The epidemiology of acute respiratory tract infection in young children: Comparison of findings from several developing countries. Rev Infect Dis. 1990;12(Suppl 8): S870-S888.
10. Ogra PL, Garofalo R. Secretory antibody response to viral vaccines. Prog Med Virol. 1990;37:156-189.
11. Ghedon Y. Influenza - its impact and control. World Health Stat Q. 1992;45:306-311.
12. Karzon DT. Control of acute lower respiratory illness in the developing world: An assessment of vaccine intervention. Rev Infect Dis. 1991;13(Suppl 6):S571-S577.
13. Osterhaus ADME, De Vries P. Vaccination against respiratory virus infections and measles in man. Immunobiology. 1992;184:180-192.
14. Henrickson KJ. Lower respiratory viral infections in immunocompetent children. Adv Pediatr Infect Dis. 1994;9:59-96.
15. Barreto ML, Santos LM. O Assis AM, et al. Effect of vitamin A supplementation on diarrhoea and acute lower-respiratory-tract infections in young children in Brazil. Lancet. 1994;344:228-231.
16. The Vitamin A and Pneumonia Working Group: Potential interventions for the prevention of childhood pneumonia in developing countries: A meta-analysis of data from field trials to assess the impact of vitamin A supplementation on pneumonia morbidity and mortality. Bull WHO. 1995;73:609-619.
17. Hemila H. Vitamin C intake and susceptibility to the common cold. Br J Nutr. 1997;77: 59-72.
18. Caramia G, Clemente E, Solli R, et al. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children. Arzneim-Forsch Drug Res. 1994;44:1480-1484.
19. Berber AC, Del-Rio-Navarro BE. Use of broncho-vaxom in private practice: Phase IV trial in 587 children. Clin Ther. 1996;18:1068-1079.
20. Berber A, Priego R, Iglesias L, et al. Induction of immune responses in nasopharyngeal secretions after oral immunization with bacterial lysates. Adv Exp Med Biol. 1995;371B: 807-811.
21. Dahan R, Constantini D, Caulin C, et al. Clinical trials with C 1740, an immunomodulator compound proposed for prevention of acute infectious exacerbations in chronic bronchitis. Methods Find Exp Clin Pharmacol. 1986;8:41-43.
22. Tovo PA, De Martino M, Rossi P, et al. Impiego della timopentina nella prevenzione delle infezioni ricorrenti dell'apparato respiratorio. Minerva Pediatr. 1993;45:505-510.
23. De Mattia D, Decandia P, Ferrante P, et al. Effectiveness of thymostimulin and study of lymphocyte-dependent antibacterial activity in children with recurrent respiratory infections. Immunopharmacol Immunotoxicol. 1993;15:447-459.
24. Gandhi A, Brodsky L, Ballow M. Benefits of antibiotic prophylaxis in children with chronic sinusitis: Assessment of outcome predictors. Allergy Proc. 1993;14:37-43.
25. Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever. Pediatrics. 1995;96:758-764.
26. Sempetegui F, Estrella B, Correa E, et al. Effects of short-term zinc supplementation on cellular immunity, respiratory symptoms and growth of malnourished Equadorian children. Ear J Clin Nutr. 1996;50:42-46.
27. Meissner HC, Fulton DR, Groothuis JR, et al. Controlled trial to evaluate protection of high-risk infants against syncytial virus disease by using standard intravenous immune globulin. Antimicrob Agents Chemother. 1993;37:1655-1658.
28. Rosèn C, Christensen P, Hovelius B, et al. Effect of pneumococcal vaccination on upper respiratory tract infection in children. Scand J Infect Dis. 1983;39:39-44.
29. Mackinnon LT, Chick TW, van As A, et al. The effect of exercise on secretory and natural immunity. Adv Exp Med Biol. 1988;216A:869-876.
30. Fitzgerald L. Exercise and the immune system. Immunol Today. 1988;9:337-339.
31. Jemmott JB III, Magloire K. Academic stress, social support and secretory immunoglobulin A. J Pers Soc Psychol. 1988;55:803-810.
32. Jemmott JB III, Borysenko JZ, Borysenko M, et al. Academic stress, power motivation, and decrease in secretion rate of salivary secretory immunoglobulin A. Lancet. 1983;1: 1400-1402.
33. McClelland DC, Alexander C, Marks E. The need for power, stress, immune function, and illness among male prisoners. J Abnorm Psychol. 1982;91:61-70.
34. Hewson-Bower B, Drummond PD. Secretory immunoglobulin A increases during relaxation in children with and without recurrent respiratory tract infections. J Dev Behav Pediatr. 1996;17:311-316.
35. Issacs D, Webster DB, Valman HB. Immunoglobulin levels and function in preschool children with recurrent respiratory infections. Clin Exp Immunol. 1984;58:335-340.
36. De Baets F, Kint J, Pauwels R, et al. IgG subclass deficiency in children with recurrent bronchitis. Eur J Pediatr. 1992;151:274-278.
37. Herrod HG, Blaiss MS, Valenski WR, et al. Cell-mediated immune status of children with recurrent infection. J Pediatr. 1995;126:530-536.
38. Ambrosino DM, Umetsu DT, Siber GR, et al. Selective defect in the antibody response to Haemophilus influenzas type b in children with recurrent infections and normal serum IgG subclass levels. J Allergy Clin Immunol. 1988;81:1175-1179.
39. Sanders LA, Rijkers GT, Tenbergen-Meekes AM, et al. Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infections. Pediatr Res. 1995;37:812-819.
40. Gigliotti F. Immunodeficiency associated with recurrent infections and isolated in vivo inability to respond to bacterial polysaccharides: Follow up immunization with pneumococcal polysaccharides. Pediatr Infect Dis J. 1988;7:604. Letter.
41. Insel RA, Anderson PW. Response to oligosaccharide-protein conjugate vaccine against Hemophilus influenzae b in two patients with IgG2 deficiency unresponsive to capsular polysaccharide vaccine. NEJM. 1986;315:499-503.
42. Bessler WG, Sedelmeir E. Biological activity of bacterial cell wall components. Arzneim-Forsch Drug Res. 1993;43:502-507.
43. Schlenter WW, Blessing R, Heintz B. Conservative treatment of chronic sinusitis. Success of oral bacterial lysate therapy. Laryngo- Rhino- Otol. 1990;69:671-674.
44. Zagar S, Lofler-Badzek D. Broncho-vaxom in children with rhinosinusitis: A double-blind clinical trial. ORL J Otorhinolaryngol Relat Spec. 1988;50:397-404.
45. Gómez-Barreto D, De-La-Torre C, Alvarez A, et al. Seguridad y eficacia de OM-85-BV más amoxicilina/clavulanato en el tratamiento de la sinusitis subaguda y prevención de infecciones recurrentes en niños. Allergol Immunopathol. 1998;26:17-22.
46. Cvoriscec B, Ustar M, Pardon R, et al. Oral immunotherapy of chronic bronchitis: A double-blind placebo-controlled multicentre study. Respiration. 1989;55:129-135.
47. Djuric O, Mihailovic-Vucinic V, Stojcic V. Effect of broncho-vaxom on clinical and immunological parameters in patients with chronic obstructive bronchitis. A double-blind, placebo-controlled study, Int J Immunother. 1989;5:139-143.
48. Orcel B, Delclaux B, Baud M, et al. Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis. Eur Respir J. 1994;7:446-452.
49. Paupe J. Immunotherapy with an oral bacterial extract (OM-85-BV) for upper respiratory infections. Respiration. 1991;58:150-154.
50. Gutiérrez-Tarango MD, Berber A. Efficacy of a bacterial extract (OM-85-BV) in preventing recurrent respiratory tract infections in susceptible children. Clin Drug Invest. 1997; 13:76-84.
51. Collet J-P, Ducruet T, Kramer MS, et al. Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. Pediatr Infect Dis J. 1993;12:648-652.
52. Girard JP, Fleury S. Analyse comparative du lévamisole et d'un lysat bactérien sur la réponse lymphocytaire in vitro. Med Hyg. 1979;37:2519-2526.
53. Maestroni GJ, Losa GA. Clinical and immunobiological effects of an orally administered bacterial extract. Int J Immunopharmacol. 1984;6:111-117.
54. Emmerich B, Emslander HP, Pachmann K, et al. Local immunity in patients with chronic bronchitis and the effects of a bacterial extract, broncho-vaxom, on T lymphocytes, macrophages, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables. Respiration. 1990;57:90-99.
55. Lusuardi M, Capelli A, Carli S, et al. Local airways immune modifications induced by oral bacterial extracts in chronic bronchitis. Chest. 1993;103:1783-1791.
56. Puigdollers JM, Serna GR, Hernández del Rey I, et al. Immunoglobulin production in man stimulated by orally administered bacterial lysate. Respiration. 1980;40:142-149.
57. Gadomski AM. Potential interventions for preventing pneumonia among young children: Lack of effect of antibiotic treatment for upper respiratory infections. Pediatr Infect Dis J. 1993;12:115-120.
58. Aymanard M, Chomel JJ, Allard JP, et al. Epidemiology of viral infections and evaluation of the potential benefit of OM-85 BV on the virologic status of children attending daycare centers. Respiration. 1994;61(Suppl 1):24-36.
59. Grove AK, Bergemann R, Keller R. Preventive treatment of chronic bronchitis: A cost effectiveness analysis for an immunoactive bacterial extract in Switzerland. Br J Med Econ. 1996;10:1-14.